Our previous study also revealed that NeuroD1 could promote tumor cell metabolic reprogramming, as it could enhance the pentose phosphate pathway (PPP) by promoting the transcription of the PPP rate-limiting enzyme G6PD [42]. Here, G6PD is linked to neoplasm.